Search Results for: netter 1

AAA reaches halfway recruitment milestone of cancer patients in Lutathera® Pivotal Phase III trial

Advanced Accelerator Applications has reached the 100-patient (halfway) milestone for the NETTER-1 study, an international Phase III clinical trial evaluating the effect of Lutathera® in patients with inoperable progressive midgut carcinoid tumors. The primary endpoint of the trial is the assessmen...

Start of Pivotal Phase III trial for Lutathera® in cancer patients with progressive midgut carcinoid

Advanced Accelerator Applications (AAA) announces the initiation of an international Phase III clinical trial evaluating the effect of Lutathera in patients with inoperable progressive midgut carcinoid. The study will be conducted at multiple centres in Europe and North America. The first European p...